Post-Stroke Hand Spasticity: Practical Clinical Guide
After a stroke, one of the sequelae most frequently affecting patients' quality of life is hand spasticity. Difficulty opening the fingers, grasping objects or performing everyday tasks such as fastening a button can represent a significant obstacle to personal autonomy. This guide addresses what spasticity is, why it occurs, what therapeutic options exist and what current scientific evidence says about each of them.
What Is Spasticity and Why Does It Appear After Stroke?
Spasticity is defined as an involuntary increase in muscle tone that manifests as resistance to passive muscle stretching. In the context of stroke, it occurs when brain injury interrupts the nerve pathways connecting the brain to the spinal cord and, through it, to the body's muscles.
Under normal conditions, the brain sends inhibitory signals that regulate the reflex activity of muscles. When a stroke damages the cortical motor areas or the descending pathways (especially the corticospinal and reticulospinal tracts), that inhibitory regulation is partially or totally lost. As a result, the spinal cord motor neurons remain in a state of hyperexcitability: they respond excessively to stretch stimuli, generating a sustained and involuntary muscle contraction.1
In the hand, this situation typically translates into a characteristic pattern: the fingers flex towards the palm, the thumb adducts (closes inward) and the wrist flexes. This pattern, when maintained over time without intervention, can lead to muscle shortening, contractures and deformities that further impede any attempt at functional movement.2
Factors Influencing the Onset of Spasticity
- Location and extent of brain injury: lesions affecting the primary motor area, internal capsule or brainstem tend to be associated with greater spasticity.
- Time elapsed since stroke: spasticity may appear from the first weeks, but tends to evolve over the following months. Early intervention can contribute to modulating this evolution.
- Level of activity and mobilisation: prolonged immobility favours the development of muscle shortening that aggravates spasticity.
- Aggravating factors: pain, urinary infections, constipation, pressure sores and other nociceptive stimuli can transiently increase spastic tone.
Understanding these mechanisms is essential because spasticity is not a static phenomenon: it is a dynamic process that can be modulated through appropriate therapeutic interventions, especially when applied early and intensively.
Therapeutic Options for Hand Spasticity
The management of post-stroke hand spasticity is necessarily multidisciplinary. There is no single intervention that resolves the problem in isolation; the combination of different strategies, adapted to each patient, is what evidence suggests as the approach with greatest potential.
1. Passive and Active-Assisted Mobilisation
A Cochrane review on passive movements for the treatment and prevention of contractures (Prabhu RKR, Swaminathan N, Harvey LA. Cochrane Database of Systematic Reviews, CD009331) determined that the level of evidence (per GRADE criteria) on the effects of isolated passive movements on spasticity, joint mobility and pain is very low with limited isolated clinical effectiveness. Although passive mobilisation is one of the most widespread and protocolised physiotherapy interventions, the review concludes that there is no strong statistical evidence that, in isolation, it produces significant long-term reductions in hypertonia or underlying pain — that is, passive mobilisation does not necessarily reduce neural spastic hypertonia or centrally-mediated pain without support from other interventions.
Scientific evidence does support that regular active mobilisation can contribute to maintaining muscle length, preventing contractures and modulating muscle tone.
Manual mobilisation has an important limitation: the number of repetitions a therapist can perform in a conventional session is relatively low. Contemporary neuroscience has demonstrated that cortical reorganisation (neuroplasticity) requires a high volume of repetitions to promote significant functional changes, in some studies above 400–600 repetitions per session.4
2. Functional Electrical Stimulation (FES)
Functional electrical stimulation (FES) is a technique that uses low-intensity electrical pulses to activate paretic muscles. For the spastic hand, FES is typically applied over wrist and finger extensors, seeking to facilitate hand opening and counteract the spastic flexor pattern.
A Cochrane review by Pomeroy et al. (2006) concluded that electrical stimulation can contribute to improving upper limb motor function when combined with other rehabilitation interventions, although the authors noted the need for additional studies with larger samples.5 More recently, a meta-analysis by Howlett et al. (2015) published in Stroke indicated that FES associated with conventional therapy can produce greater hand function improvements than those observed with conventional therapy alone.6
FES can be applied in isolation or integrated into robotic devices, allowing electrical stimulation to be synchronised with assisted movement of the upper limb rehabilitation robot.
3. Robotic Upper Limb Rehabilitation
Robotic rehabilitation represents one of the most relevant advances in the field of neurorehabilitation over the past two decades. Robotic devices can assist, guide and record hand and arm movements, providing an intensive, repetitive and quantifiable practice environment.
Using an upper limb rehabilitation robot in spastic hand rehabilitation offers several advantages over conventional manual techniques:
- High volume of repetitions: robotic devices can facilitate hundreds or thousands of movements per session, far exceeding the number of repetitions achievable in manual therapy.
- Precise assistance control: the robot adapts help to the patient's capacity level, providing only the assistance needed to complete the movement (assist-as-needed principle).
- Objective feedback: integrated sensors record parameters such as force, range of motion and speed, allowing objective monitoring of patient progress.
- Motivation and adherence: many devices include gamified interfaces that can contribute to maintaining patient motivation during extended sessions.
Scientific evidence on robotic upper limb rehabilitation after stroke is considerable. A Cochrane review by Mehrholz et al. (2018), which included 45 clinical trials with more than 1,600 participants, concluded that robot-assisted therapy can contribute to improving upper limb function and activities of daily living in post-stroke patients, particularly when used as a complement to conventional therapy.7
A randomised controlled trial published by Rodgers et al. (2019) in The Lancet (RATULS study) provided important nuances: although robotic rehabilitation did not demonstrate superiority over equally intensive conventional therapy, it did prove superior to non-intensive usual care, underscoring the importance of therapeutic intensity regardless of the medium used.8
The key is not just the technology, but the intensity and repetition that technology enables. The upper limb rehabilitation robot is a tool that helps the physiotherapist provide the therapeutic dose that scientific evidence suggests is necessary to promote neuroplasticity.
4. Botulinum Toxin (Medical Context)
Botulinum toxin type A is a pharmacological treatment that acts by temporarily blocking the release of acetylcholine at the neuromuscular junction, thereby reducing excessive muscle contraction. Its indication and administration is exclusively the responsibility of the specialist physician (usually rehabilitation physician or neurologist).
A meta-analysis by Rosales et al. (2012) published in the Journal of Neurology concluded that botulinum toxin injection can contribute to reducing muscle tone and improving hand position in patients with post-stroke spasticity.9 However, the authors highlighted that the effects on active hand function are more modest and depend greatly on the injection being accompanied by an active rehabilitation programme.
It is important to emphasise that botulinum toxin does not constitute an isolated treatment: its greatest potential manifests when combined with intensive physiotherapy and, in particular, with repetitive mobilisation facilitated by robotic devices. The temporary reduction in spastic tone it provides can open a therapeutic window in which the patient can benefit more from active rehabilitation.10
The Importance of Early Intervention
One of the factors that scientific evidence identifies as most relevant in the functional prognosis of the hand after stroke is the time elapsed before starting rehabilitation. The concept of the neuroplasticity window refers to the period, especially the first three to six months after brain injury, in which the central nervous system shows a greater capacity for reorganisation.11
During this period, intensive therapeutic interventions can potentially have a greater impact on functional recovery. A study by Biernaskie et al. (2004), though conducted in an animal model, demonstrated that early initiation of rehabilitation (within the first weeks after injury) was associated with greater reorganisation of cortical maps compared with delayed initiation.12
In the clinical context, this does not mean rehabilitation is pointless outside that period: evidence suggests neuroplasticity persists throughout life, though with less intensity. What it does indicate is that each week of delay in starting an intensive rehabilitation programme may represent a missed opportunity.
Early intervention is especially relevant for the hand because spasticity, if not addressed promptly, can trigger a cycle of immobility, muscle shortening and contracture that becomes progressively harder to reverse. Repetitive mobilisation with an upper limb rehabilitation robot, initiated in the early phases of rehabilitation, can contribute to interrupting this cycle and maintaining the hand in the best possible condition for functional recovery.
The GNeuro Approach: Robotic Technology in the Service of Neurorehabilitation
At GNeuro, a robotic neurorehabilitation centre located in Ourense, we have an upper limb rehabilitation robot specifically designed for upper limb rehabilitation, including the hand. This device allows high-intensity repetitive mobilisation sessions to be performed under the direct supervision of a physiotherapist specialised in neurological damage.
Our approach is based on the principles that current scientific evidence identifies as fundamental for effective neurorehabilitation:
- Therapeutic intensity: the upper limb rehabilitation robot allows a significantly higher volume of repetitions to be achieved than conventional manual therapy.
- Task specificity: the movements performed reproduce functional patterns relevant to activities of daily living (hand opening and closing, gripping, finger extension).
- Continuous feedback: the patient receives visual and proprioceptive information about their performance, which can contribute to enhancing motor learning mechanisms.
- Individualised programme: each treatment plan is designed in a personalised manner, adapting robot parameters (assistance level, range of motion, speed) to each patient's needs and abilities.
- Multidisciplinary integration: robotic rehabilitation is integrated within a comprehensive programme that may include conventional physiotherapy, speech therapy and coordination with the medical team responsible for the patient.
Our team, with more than a decade of experience in the rehabilitation of patients with neurological damage in the public hospital setting, transfers that clinical knowledge to a model of specialised care that complements public healthcare resources.
What to Expect from the Rehabilitation Process
It is important to maintain realistic and well-founded expectations. Rehabilitation of post-stroke hand spasticity is a gradual process requiring consistency, dedication and time. There are no immediate solutions and the final functional outcome cannot be predicted with certainty, as it depends on multiple individual factors.
What scientific evidence does allow us to state is that an intensive, early rehabilitation programme based on the repetition of functional movements can contribute to improving range of motion, reducing spastic tone, promoting voluntary muscle activation and facilitating patient participation in activities of daily living.
The role of the upper limb rehabilitation robot in this process is that of a tool that allows the physiotherapist to achieve a therapeutic dose that would otherwise be difficult to achieve within the available time of a clinical session. Technology serves rehabilitation; it does not replace it.
Frequently Asked Questions
When should hand rehabilitation begin after a stroke?
Scientific evidence suggests that starting rehabilitation early, ideally in the first weeks after stroke, can contribute to better functional outcomes. The medical team will determine the appropriate time in each individual case, assessing the patient's clinical stability. At GNeuro we carry out an initial assessment to establish a therapeutic plan adapted to the phase of each person.
Is post-stroke hand spasticity painful?
Spasticity can be associated with discomfort or pain, especially when it limits movement or causes sustained forced postures over a prolonged period. Not all patients experience pain, but in cases where it appears, therapeutic approaches exist that can contribute to its management, including guided mobilisation with an upper limb rehabilitation robot, gentle stretching and, in some cases, pharmacological treatment under medical supervision.
What role does robotic rehabilitation play in hand spasticity?
Rehabilitation with an upper limb rehabilitation robot allows a high number of guided and precise hand movement repetitions to be performed. Scientific evidence suggests that this type of intensive and repetitive therapy can contribute to improving motor function and reducing spasticity, as a complement to an individualised neurorehabilitation programme. The device does not replace the physiotherapist, but allows the intensity of the intervention to be amplified.
Can post-stroke hand spasticity be treated in the chronic phase?
Yes. Although evidence suggests early intervention may be associated with better outcomes, neuroplasticity does not disappear completely with time. Patients in the chronic phase (more than six months after stroke) can benefit from intensive rehabilitation programmes, although therapeutic goals are adapted to the realistic possibilities of each case. A specialist assessment allows realistic expectations to be established and an appropriate intervention plan to be designed.